Sunrest Lifescience Complete Financial Statements
SUNREST • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Sunrest Lifescience (SUNREST).
Downloads include all available records across all periods.
For market performance, see the
SUNREST stock price today
.
Profitability Ratios
Net Profit Margin
6.06%
2025 data
EBITDA Margin
9.09%
2025 data
Operating Margin
9.00%
2025 data
Return on Assets
5.71%
2025 data
Return on Equity
12.50%
2025 data
Balance Sheet Ratios
Current Ratio
7.00
2025 data
Debt to Equity
2.19
2025 data
Equity Ratio
45.71%
2025 data
Asset Turnover
0.94
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-42.4%
Year-over-Year
EBITDA Growth
-66.7%
Year-over-Year
Expense Growth
-40.0%
Year-over-Year
Assets Growth
+40.0%
Year-over-Year
Equity Growth
+14.3%
Year-over-Year
Liabilities Growth
+40.0%
Year-over-Year
Operating Cash Flow Growth
+106.7%
Year-over-Year
Financing Cash Flow Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 19 | 33 | 30 | 25 | 27 | 17 | 11 |
| Expenses | 18 | 30 | 29 | 22 | 26 | 17 | 11 |
| EBITDA | 1 | 3 | 1 | 3 | 1 | 0 | 0 |
| Operating Profit Margin % | 6.00% | 9.00% | 3.00% | 12.00% | 4.00% | 2.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 3 | 1 | 3 | 1 | 0 | 0 |
| Tax | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
| Net Profit | 2 | 2 | 0 | 2 | 1 | 0 | 0 |
| Earnings Per Share (₹) | 6.60 | 4.66 | 0.68 | 6.81 | 2.59 | 1.66 | 0.37 |
Related Pages for Sunrest Lifescience
Additional stock information and data for SUNREST
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 35 | 25 | 17 | 13 | 10 | 6 |
| Current Assets | 28 | 25 | 16 | 13 | 9 | 6 |
| Fixed Assets | 1 | 0 | 0 | 1 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 34 | 25 | 16 | 13 | 9 | 6 |
| LIABILITIES | ||||||
| Total Liabilities | 35 | 25 | 17 | 13 | 10 | 6 |
| Current Liabilities | 4 | 4 | 2 | 3 | 2 | 2 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 16 | 14 | 3 | 1 | 0 | 0 |
| Share Capital | 4 | 4 | 3 | 0 | 0 | 0 |
| Reserves & Surplus | 12 | 10 | 0 | 1 | 0 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | 1 | -15 | 1 | 0 | 0 | -1 |
| Investing Activities | -1 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 15 | -1 | 1 | 0 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |